NephroGenex Protocol PRY-311 : A Phase 3 Randomized, Double-Blind,Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (pyridoxamine dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes.
Clinical Trial Grant
Administered By
Medicine, Nephrology
Awarded By
Medpace, Inc
Start Date
July 1, 2014
End Date
February 13, 2018
Administered By
Medicine, Nephrology
Awarded By
Medpace, Inc
Start Date
July 1, 2014
End Date
February 13, 2018